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ABSTRACT 
Background: Glucose is considered as one of the main sources of cell damage related to aldose 
reductase (AR) action in hyperglycemic conditions and a worldwide effort is posed in searching for 
specific inhibitors of the enzyme. This AR substrate has often been reported as generating non 
hyperbolic kinetics, mimicking a negative cooperative behavior. This feature was explained by the 
simultaneous action of two enzyme forms acting on the same substrate.  
Methods: The reduction of different aldoses and other classical AR substrates was studied using 
pure preparations of bovine lens and human recombinant AR. 
Results: The apparent cooperative behavior of AR acting on glucose and other hexoses and 
pentoses, but not on tethroses, glyceraldehyde, 4-hydroxynonenal and 4-nitrobenzaldehyde, is 
generated by a partial nonclassical competitive inhibition exerted by the aldose hemiacetal on the 
reduction of the free aldehyde. A kinetic model is proposed and kinetic parameters are determined 
for the reduction of L-idose. 
Conclusions: Due to the unavoidable presence of the hemiacetal, glucose reduction by AR occurs 
under different conditions with respect to other relevant AR-substrates, such as alkanals and 
alkenals, coming from membrane lipid peroxidation. This may have implications in searching for 
AR inhibitors. The emerging kinetic parameters for the aldoses free aldehyde indicate the 
remarkable ability of the enzyme to interact and reduce highly hydrophilic and bulky substrates. 
General Significance: The discovery of aldose reductase modulation by hemiacetals offers a new 
perspective in searching for aldose reductase inhibitors to be developed as drugs counteracting the 
onset of diabetic complications. 
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1 INTRODUCTION 
The NADPH-dependent reduction of D-glucose catalyzed by aldose reductase (E.C.1.1.1.21) (AR) 
is considered as one of the phenomena leading to the onset of long term diabetic complications [as 
review see: 1, 2]. In fact, the reduction of the sugar, which occurs mainly in hyperglycemic 
conditions, is associated with a number of deleterious events. Stressful and damaging cell 
conditions are caused by a number of factors: the osmotic imbalance due to sorbitol accumulation 
[3], the loss of reducing, and thus, antioxidant power associated to NADPH oxidation [4] and the 
induction of more favorable conditions for protein glycation [5]. This led a strong impulse in the 
search for molecules able to efficiently inhibit the enzyme (aldose reductase inhibitors, ARIs) with 
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the aim to develop active drugs to antagonize the onset of diabetic complications. Several powerful 
ARIs have been proposed on the basis of their in vitro action, however the promotion of those 
molecules for effective drugs was not very successful; to date Japan and India are the only countries 
where an Epalrestat-based drug is distributed. This is likely due to the ability of AR to act on toxic 
hydrophobic aldehydes, derived from lipid peroxidation processes, such as trans-4-hydroxy-2,3-
nonenal (HNE) [6, 7], whose reduction attenuates their cytotoxicity. Thus, AR inhibition would no 
longer appear to be a useful approach in favoring cell health [8-10]. Nevertheless, several 
experimental evidences suggest an anti-inflammatory action of ARIs [11]; this on the basis of the 
ability of AR to reduce the adduct between HNE and glutathione, generating a pro-inflammatory 
signal [6, 7, 12-14]. More recently a new approach to control AR activity by differential inhibition 
was proposed [15]. In this case, the inhibitors (AR differential inhibitors, ARDIs) should be able to 
inhibit AR while acting on glucose, but not on molecules such as HNE, whose breakdown is part of 
the detoxifying action exerted by AR.  
The reaction rate of AR as a function of substrate concentration has been reported to display, in 
some instances, a negative cooperative type of behavior [16-26]. As AR is unequivocally a 
monomeric enzyme, the observed negative cooperativity was associated to the presence, in the 
enzyme preparations, of two enzyme forms, which were often referred to as the “unactivated” and 
the “activated” enzyme and displayed different kinetic properties, including a different 
susceptibility to inhibition by ARIs and by substrates [16, 18, 21, 25, 26]. Indeed, a fascinating and 
intriguing mechanistic explanation has been proposed to justify, despite the presence of the two 
enzyme forms, the hyperbolic behavior occasionally observed with glyceraldehyde or glycol 
aldehyde [27]. None of the above considerations are easy to rationalize, since in the literature it is 
difficult to find a common established procedure for enzyme preparation and manipulation in order 
to define which form of AR is present. 
Although it has been reported that AR from the human psoas muscle could be modified by 
treatment with pyridoxal phosphate followed by NaBH4 treatment [28], the only reversible covalent 
modification assessed for the enzyme to date has been the thiolation of Cys298. This is induced by 
different thiol compounds, including 2-mercaptoethanol (2-ME), in oxidative conditions, with 
consequent possible intramolecular trans-thiolation arrangements [29-34]. In addition, a S-
glutathionyl-modified AR, a relatively stable enzyme form, not susceptible to Sorbinil inhibition 
and still sensitive to dithiothreitol (DTT) reduction, has been generated in situ in intact bovine 
lenses undergoing oxidative stress [35, 36]. On this basis, the occurrence of an apparent negative 
cooperative behavior that has been reported for the reduction of different substrates could be 
associated with the presence in pure enzyme preparations of enzyme forms with an altered cysteine 
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redox status, deriving from inappropriate thiol-reducing conditions (i.e. the use of 2-ME) adopted 
during enzyme purification and storage [29]. 
In this study, using pure enzyme preparations of human placental recombinant AR (hAR) and of 
AR isolated from bovine lens (bAR), which behave as Michaelis enzymes with glyceraldehyde as 
substrate, is shown that an apparent negative cooperativity action for glucose still occurs. We 
present evidence for a partial inhibitory action of the hemiacetal form of aldoses on the AR activity. 
A kinetic model is proposed to explain the apparent negative cooperative behavior observed for 
glucose and more generally for aldoses that are able to produce cyclic hemiacetal structures. 
 
 
2 Materials and Methods 
 
2.1 Materials 
L-glucose, L-idose, L-sorbose and L-threose were from Carbosynth. D-fructose, D-glucose, D,L-
glyceraldehyde (GAL), NADPH, 4-nitrobenzaldehyde and D-ribose were from Sigma Aldrich. DTT 
was from Inalco. HNE was prepared as described [37]. All other chemicals were of reagent grade.  
 
2.2 Assay of aldose reductase. 
The activity of AR was determined at 37°C following the decrease in absorbance at 340 nm due to 
NADPH oxidation (ε340 = 6.22 mM-1.cm-1). The standard assay mixture contained 0.25 M sodium 
phosphate buffer pH 6.8, 0.18 mM NADPH, 2.4 M ammonium sulfate, 0.5 mM EDTA and 4.7 mM 
GAL. One unit of enzyme activity is the amount that catalyzes the conversion of 1 µmol of 
substrate/min in the above assay conditions. The above assay conditions were adopted also when D-
glucose or L-idose were used as substrates instead of GAL. 
 
2.3 Purification of human recombinant and bovine lens AR. 
The hAR was expressed as previously described [38]. Both bAR and hAR were purified following 
essentially the same procedure [39]. The purity of enzyme preparations was assessed by SDS-
PAGE [40] and gels were stained with silver nitrate [41]; both enzyme preparations showed a 
unique band corresponding to a molecular weight of approximately 34 KDa. The specific activity of 
purified bAR and hAR was 1.2 and 5.3 U/mg, respectively. The purified bAR and hAR were stored 
at -80 °C in 10 mM sodium phosphate buffer pH 7.0 (SB) containing 2 mM DTT alone or with 30% 
(w/v) glycerol, respectively. Both enzymes were extensively dialyzed against SB before use.  
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2.4 Other methods. 
Protein concentration was determined according to Bradford [42].  
“GraphPad 6.0” was used for statistical analysis and for determination, by hyperbolic nonlinear 
regression analysis, of kinetic parameters. The analysis was performed for different substrates on 
two sets of data, referring to “low” and “high” substrate concentration ranges, which are specified 
for the different aldoses. Double reciprocal plots of kinetic measurements are adopted only for 
presentation of experimental data. The straight lines in these plots were drawn on the basis of the 
kinetic parameters (i.e. intercepts on the ordinate and abscissa axes) derived from nonlinear 
regression analysis of experimental data. To determine the fitting curve for nonrectangular 
hyperbolic functions (i.e. 𝑦 = (𝑎 + 𝑏𝑥) (𝑐 + 𝑑𝑥)⁄ ), as is the case of data reported in Fig. 6 and Fig. 
7, inset, a least squares method was used. The optimization of the parameters for determining the 
best fit was performed with the Levenberg-Marquardt algorithm; the computations were performed 
with the symbolic mathematical computational software “Mathematica”.  
The concentrations of the free aldehyde form of D-glucose and L-idose were calculated from the 
following percentage of open chain: 1.28 x 10-3 % and 87.70 x 10-3 %, respectively [43]. 
 
3 RESULTS  
3.1 Kinetic analysis of aldoses reduction by AR. 
Rate measurements of glucose reduction catalyzed by bAR and hAR, performed using a wider 
range of substrate concentration than previously adopted [38], are reported in Fig. 1. The resulting 
behavior appears consistent with a complex kinetic mechanism mimicking an apparent negative 
cooperative model of action. Through nonlinear regression analysis, two different values for 
apparent KM (74.9 ± 3.2 and 8.5 ± 2.9 mM for bAR and 204.6 ± 20.4 and 24.1 ± 7.6 mM for hAR) 
and kcat (0.84 ± 0.02 and 0.14 ± 0.03 s
-1 for bAR and 1.84 ± 0.09 and 0.28 ± 0.13 s-1for hAR) were 
determined for the high and low range of glucose concentrations, respectively. The high and low 
range of glucose concentrations refer to: for hAR 12-400 mM and 5.5-10 mM, respectively; for 
bAR 6.5-100 mM and 3-6 mM, respectively. 
In this study, to avoid the generation of different oxidized enzyme forms, pure enzyme preparations 
freshly dialyzed against SB to remove 2 mM DTT present during storage at –80°C, were used. In 
addition, pure enzyme preparations still containing DTT (0.1 mM final concentration in the assay 
mixture) generate, using glucose as substrate, a biphasic curve as those of Fig. 1 (data not shown). 
On the other hand, a linear behavior in double reciprocal plots for GAL, D-erythrose, L-threose, 
HNE, and 4-nitrobenzaldehyde was observed (Fig. 2). A unique straight line could be drawn for 
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these substrates when the nonlinear regression analysis was performed on two sets of rate 
measurements, at high and low substrate concentrations (data not shown). 
In order to assess whether the biphasic kinetics is a particular feature of glucose reduction, different 
long chain aldoses (more than 4 carbon atoms) were tested as substrates for AR in a wide range of 
substrate concentrations. Double reciprocal plots of the hAR-catalyzed reduction of D-Galactose, L-
idose, D-Ribose and D-xylose are reported in Fig. 3. As shown, irrespectively of their apparent 
effectiveness as substrates, all the tested molecules display a biphasic behavior, since for all of them 
it is possible to evaluate limiting values of apparent kinetic parameters (see Section 2.4) for the high 
and low substrate concentration ranges (data not shown). 
 
3.2 A kinetic model for aldose reduction by AR 
In order to verify the potential of the multiple interaction of aldose hemiacetal and free aldehyde 
components on AR as causative of the apparent negative behavior displayed by glucose and other 
aldoses undergoing reduction, different partial inhibition pathways, namely, the nonclassical 
competitive, the mixed noncompetitive and the uncompetitive, were considered (Fig. 4 Panels A, B 
and C, respectively). No specific restrictions are imposed on the values of the kinetic constants k+2 
and k+4 except that they should not to be significantly different. Here is considered that the aldose 
free aldehyde form is the only one susceptible to reduction [44] and that the ternary complex 
between AR, the free aldehyde and the aldose hemiacetal is still able to generate products. It is 
worth noting that a possible competition between the aldose hemiacetal and the free aldehyde as 
substrates for the enzyme does not explain the apparent negative cooperative behavior observed for 
aldoses reduction [45] (see also Appendix-Sect.V). On the other hand, there is evidence that AR is 
unable to catalyze the ring opening of glucose hemiacetal [46]. 
By considering the interaction steps of the substrate (A) as in a steady state condition and those 
involving the hemiacetal (C) at the equilibrium, the above kinetic models were analyzed. 
The nonclassical competitive model (Fig. 4 A) proposes that the hemiacetal form (C) can 
specifically interact with the free enzyme, allowing the free aldehyde substrate (A) to still enter into 
the catalytic site and undergo reduction. 
The general rate equation  for this model can be written as: 
𝑣0 =
𝑑[𝑃]
𝑑𝑡
=  𝑘+2[𝐸𝐴] + 𝑘+4[𝐸𝐶𝐴]    (1) 
By applying equilibrium conditions for all the equilibrium steps [47], or the steady state condition 
for EA and ECA and considering the EC complex at the equilibrium, the following kinetic equation 
can be formulated for the transformation of the substrate (see Appendix-Sect.I):  
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𝑣0 =
𝐸𝑇
𝑘+2 𝐾𝑚
′ 𝐾𝑖+𝑘+4𝐾𝑚[𝐶]
𝐾𝑚[𝐶]+ 𝐾𝑚
′ 𝐾𝐸𝐶
[𝐴]
𝐾𝑚 𝐾𝑚
′ (𝐾𝑖+[𝐶])
 𝐾𝑚
′ 𝐾𝑖+𝐾𝑚[𝐶]
+[𝐴]
                      (2) 
where 𝐾𝑚 = (𝑘+2 + 𝑘−1) 𝑘+1⁄   and  𝐾𝑚
′ = (𝑘+4 + 𝑘−3) 𝑘+3⁄  represent the Michaelis constants for 
the free aldehyde of E and EC, respectively, while 𝐾𝑖 represents the dissociation constant of EC. 
Equation 2 enables the effect exerted on the reaction rate by either the hemiacetal or the sugar free 
aldehyde to be predicted. When one of these two terms is kept constant, as shown, for instance, for 
C in the Eq.2, the dependence of the reaction rate on the other one is hyperbolic. 
In order to interpret the biphasic behavior of glucose and, more generally, of aldose reduction (Fig. l 
and Fig. 3), Eq.2 was rewritten by expressing [𝐶] and [𝐴] in terms of total glucose 
concentration  [𝐺]. Thus, given that: 
[𝐶] + [𝐴] = [𝐺]   and         
[𝐶]
[𝐴]
= 𝑅 
it follows that: 
[𝐴] =
[𝐺]
𝑅+1
     and    [𝐶] =
𝑅[𝐺]
𝑅+1
 
The substitution of these terms in Eq.1 and simple algebra steps gives Eq.2 (see Appendix-Sect.I): 
𝑣0 =
𝐸𝑇{𝑘+2 𝐾𝑚
′  𝐾𝑖
′(𝑅+1)[𝐺]+𝑘+4𝐾𝑚𝑅[𝐺]
2}
 𝐾𝑚𝐾𝑚
′ 𝐾𝑖(𝑅+1)2+ 𝐾𝑚
′ (𝐾𝑚𝑅+𝐾𝑖)(𝑅+1)[𝐺]+𝐾𝑚𝑅[𝐺]2
 …(3) 
Equation 3 describes a complex kinetic behavior that fits the data of the reaction rates of the AR-
catalyzed aldose reduction as a function of the nominal aldose concentration (Figs. 1 and 3) In fact, 
using the kinetic parameters determined in the present study for L-idose reduction (see below) and 
taking into account the free aldehyde present in L-idose solutions [43], a computer-assisted 
simulation enables calculated curves for L-idose to fit with kinetic measurements (Fig. 5, curve 1).  
When considering the mixed type of inhibition (Fig. 4 B), starting from the general kinetic 
equation: 
𝑣0 =
𝑑[𝑃]
𝑑𝑡
=  𝑘+2[𝐸𝐴] + 𝑘+4[𝐸𝐴𝐶]       (4) 
a kinetic equation as a function of both hemiacetal and free aldehyde concentration (Eq.5), can be 
obtained (see Appendix-Sect.II): 
𝑣0 =
𝐸𝑇(  𝑘+2𝐾𝑚
′  𝐾𝑖
′  𝐾𝑖+ 𝑘+4(𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐶])
 𝐾𝑚
′  𝐾𝑖
′  𝐾𝑖 + (𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐶]
[𝐴]
𝐾𝑚 𝐾𝑚
′ 𝐾𝑖
′(𝐾𝑖+[𝐶])
 𝐾𝑚
′  𝐾𝑖𝐾𝑖
′ + (𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐶]
  + [𝐴]
       (5) 
When expressed in terms of nominal aldose concentration (i.e. [G]) Eq.5 becomes: 
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𝑣0 =
𝐸𝑇{𝑘+2 𝐾𝑚
′ 𝐾𝑖 𝐾𝑖
′(𝑅+1)[𝐺]+𝑘+4𝑅(𝐾𝑚 𝐾𝑖
′+ 𝐾𝑚
′ 𝐾𝑖)[𝐺]
2}
𝐾𝑚 𝐾𝑚
′ 𝐾𝑖 𝐾𝑖
′(𝑅+1)2+ 𝐾𝑚
′  𝐾𝑖
′(𝑅+1)(𝐾𝑚𝑅+𝐾𝑖)[𝐺]+ 𝑅(𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐺]2
      (6) 
Thus, also this mechanism of inhibition may explain the downwards curvature observed in double 
reciprocal plots for AR catalyzed reduction of the aldoses. This occurs, however, only when a more 
favorable binding of the hemiacetal to E, with respect to EA, occurs. In fact, as shown in Fig. 5, a 
shift from an upward curvature to a downward curvature (curves 2 to 5) occurs when 𝐾𝑖
′ 𝐾𝑖⁄  was 
increased from 0.5 to 50. As shown, at the highest  𝐾𝑖
′ 𝐾𝑖 ⁄  ratio the curve is essentially 
superimposable to curve 1 coming from Eq.3. 
Different is the case of an exclusive interaction of C with the EA complex (Fig. 4 C). For this partial 
uncompetitive model of action in which, even not shown, the EC complex generated from the 
catalytic step promptly dissociates, the emerging kinetic equations in terms of both hemiacetal and 
free aldehyde concentration (Eq.7) and in terms of total aldose concentration (Eq.8) resulted: 
𝑣0 =
𝐸𝑇(𝑘+2 𝐾𝑖
′+𝑘+4[𝐶])
( 𝐾𝑖
′+[𝐶])
[𝐴]
𝐾𝑚 𝐾𝑖
′
 𝐾𝑖
′+[𝐶]
+[𝐴]
    (7) 
𝑣0 =
𝐸𝑇{𝑘+2 𝐾𝑖
′(𝑅+1)[𝐺]+𝑘+4𝑅[𝐺]
2}
𝐾𝑚 𝐾𝑖
′(𝑅+1)2+ 𝐾𝑖
′(𝑅+1)[𝐺]+𝑅[𝐺]2
            (8) 
Equation 8 would appear in the double reciprocal plots with an upward curvature, as occurs for 
apparent positive cooperativity or substrate inhibition models (data not shown). This would not fit 
with the downward curves observed for long chain aldoses (Figs. 1 and 3). 
 
3.3 Interaction of hemiacetals with AR. 
The potential of a partial inhibitory action exerted by the hemiacetal form on the aldose reduction 
was verified by evaluating the effect exerted by D-glucose on the reduction of L-idose. This was 
achieved by measuring NADPH oxidation using as a substrate 0.4 mM L-idose (a concentration 
which accounts for 0.35 µM of L-idose free aldehyde) with different concentrations of D-glucose in 
a sufficiently low range (up to 4 mM, accounting for 0.05 µM of the free aldehyde) so as not to 
impact on the overall AR-dependent oxidation of the cofactor (Fig. 6). In these conditions there was 
an inhibitory action of D-glucose on L-idose reduction of approximately 10 % at the highest tested 
concentration. When L-glucose, which is not recognized as a substrate for AR (no activity could be 
detected in standard assay conditions with 30 mM of the sugar), was used instead of D-glucose as a 
source of hemiacetal, a maximal inhibition of 17 % was evaluated. The same figure shows that 
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hemiketals, such as D-fructose and L-sorbose, were ineffective in modulating the AR-dependent 
reduction of L-idose. Finally, we found that L-glucose inhibits the reduction of D-ribose. 
In order to explore the model of partial inhibition exerted by hemiacetals on the AR-catalyzed L-
idose reduction, a set of assay mixtures was assembled to evaluate the dependence of the reaction 
rate on the concentration of L-idose, with different fixed levels of hemiacetal. This was achieved by 
complementing with L-glucose the difference in hemiacetal concentration occurring at different L-
idose concentrations. When reported in double reciprocal plots, the reaction rates measured at 
different substrate concentrations appear as straight lines that nearly converge on the ordinate axis, 
with slopes that increase with the increase in L-glucose concentration (Fig. 7). This result is 
expected for all the considered inhibition models on the basis of Eqs.2, 5 and 7.  
Having made no assumptions on the relative values of k+2 and k+4 (Fig. 4), except for not significant 
differences among them,  𝑉𝑚𝑎𝑥
𝑎𝑝𝑝 will change for all the models from k+2ET to k+4ET with the increase 
in [C] through a hyperbolic function of general form y = (a+bx)/(c+dx) (see Appendix-Sect.IV). In 
contrast, the 𝐾𝑀
𝑎𝑝𝑝
 values, through a similar hyperbolic function, will increase with the increase in 
[C] in the case of nonclassical competitive interaction, while they will decrease in the case of 
uncompetitive interaction. In the case of the mixed type of inhibition 𝐾𝑀
𝑎𝑝𝑝
 values versus [C] 
concentration will either increase or decrease, through a hyperbolic function, from 𝐾𝑚 towards the 
limit value of 𝐾𝑚 𝐾𝑖
′ or  𝐾𝑚
′  𝐾𝑖 depending on the relative values of 𝐾𝑖 and  𝐾𝑖
′. 
The secondary plot of apparent KM values (Fig. 7, inset), derived from nonlinear regression analysis 
of data shown in Fig. 7, enables the relative affinity of the aldose free aldehyde for the free AR to 
be assessed, as well as for the hemiacetal-bound enzyme (see Appendix, Sect.I and Sect.IV). As it is 
impossible to measure the enzyme activity in the absence of the hemiacetal, the limit apparent KM 
values at zero (𝐾𝑚) and at saturating ( 𝐾𝑚
′ ) hemiacetal concentrations were determined by analyzing 
the secondary plot curve (Fig. 7, inset) by a nonlinear fitting method using a general equation y = 
(a+bx)/(c+dx) (see Section 2.4). Thus, we were able to estimate values of 1.0 ± 0.6 µM and 3.4 ± 
0.5 µM for 𝐾𝑚 and  𝐾𝑚
′ , respectively. Similarly, the apparent Vmax values (derived from nonlinear 
regression of data of Fig. 7) were analyzed by a nonlinear fitting method (Fig. 7, inset). A tendency 
to increase of Vmax from 0.014 ± 0.005 mM min
-1 to 0.026 ± 0.002 mM min-1 was evaluated. 
 
 
4 DISCUSSION 
The biphasic kinetic behavior occasionally reported for the reduction of different substrates, 
including D-glucose, by AR and associated with the possible presence of two enzyme forms [16, 
18, 21, 25, 26], was also observed in the present work, in which all precautions were taken to 
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prevent an oxidative modification of the purified bAR and hAR. Thus, DTT, as thiol reducing 
agent, and EDTA (also present in the AR assay mixture) never left AR during extraction and 
purification (except, necessarily, for the time needed to perform the affinity chromatography step). 
In addition, the use of 2-ME was completely avoided. In fact, 2-ME, so often used as a preservative 
for reduced thiols, has been found to be a very efficient trigger of AR oxidative modification, when 
often uncontrolled factors (storage time and conditions, temperature, traces of transition metal ions, 
disulfides) induce its full or partial oxidation [29]. Paradigmatic is the reported evidence of a 
purified AR preparation that was isolated from human psoas muscle in the presence of 5 mM 2ME 
and which resulted to be inactivated (we would say re-converted to its native form) by DTT, but not 
by 2ME [48]. Finally, the ionic strength stress, as occurs during ammonium sulfate fractionation, 
which forces the release from AR of the bound pyridine cofactor [39], especially during earlier 
purification steps, was avoided in order to preserve AR in its native state [30, 49]. 
With the above-mentioned precautions, the final highly-purified preparations of both bAR (data not 
shown) and hAR behave, as expected, as monomeric catalysts characterized by simple hyperbolic 
kinetics when D-erythrose, L-threose, GAL, HNE and 4-nitrobenzaldehyde were used as substrates 
in a range of concentrations in which substrate inhibition phenomena can be ruled out (Fig. 2). The 
linearity observed with GAL, L-threose or D-erythrose by itself does not rule out the presence of 
two enzyme forms. In fact an inhibitory adduct between the enol form of the substrate and the 
oxidized pyridine cofactor, which would mask the biphasic behavior expected as a consequence of 
the presence of two enzyme forms, can be generated [27]. However, the linearity observed with 
HNE, which is more susceptible as a target by nucleophilic attack at the C3 than as nucleophile on 
the pyridine ring of NADP+, and with 4-nitrobenzaldehyde, a molecule that is unable to enolize and 
therefore is not able to generate the inhibitory adduct, confirms the absence of different forms of 
AR in the used enzyme preparations. 
The results obtained with D-glucose (Fig. 1) enable two couples of kinetic parameters to be 
estimated, namely KM and kcat, measured at high and at low substrate concentrations. For each 
kinetic parameter an approximately 10 fold difference was observed between the high and low 
range of substrate concentration. These results explain the wide range of kinetic parameters values 
reported to date for glucose in the literature [30, 50-54]. However, having ruled out the presence of 
two enzymatic forms concurring to the reduction of glucose, as is the case of the present study, 
interpreting the above apparent kinetic parameters becomes conceptually difficult. 
Thus, the observed apparent negative cooperative reduction of D-glucose was associated with the 
particular features of this substrate, rather than with the combined action of two different enzyme 
forms. We found that this effect was the result of a partial inhibitory action exerted by the glucose 
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hemiacetal on the reduction of glucose free aldehyde. This biphasic behavior is not unique for D-
glucose, but is a general feature of the long chain aldoses that generate cyclic hemiacetals. In fact, 
the reduction processes of L-idose, D-galactose, D-ribose and D-xylose catalyzed by hAR, all 
display apparent negative cooperative features (Fig. 3). It thus follows that the proposed interaction 
of cyclic hemiacetal with the enzyme is not a special feature of glucose hemiacetal, but applies to 
the hemiacetal structures of the tested 5 and 6 carbon atom aldoses, which all modulate the 
reduction of their respective open aldehyde forms. 
We found evidence of the interaction between AR and hemiacetals by evaluating the effect of 
glucose on L-idose reduction. L-idose was recently proposed as the best AR substrate able to mimic 
glucose [38]. This aldose is structurally very closely related to D-glucose, from which it differs only 
in the stereo chemical configuration of the C5 carbon atom. The two aldoses, however, significantly 
differ in terms of the content of the free aldehyde, with L-idose, of the aldoses, having one of the 
highest contents of the free aldehyde form in aqueous solution (60 to 80 fold higher than glucose) 
[43]. Given that glucose free aldehyde represents approximately only 1.28 x 10-3 % of total glucose, 
we verified the effect of the hemiacetal form of glucose on L-idose reduction by avoiding the 
interference exerted by the reduction of glucose itself. Using 0.4 mM L-idose as substrate, a modest 
inhibition, progressively increasing up to approximately 10% of the initial enzyme activity, was 
observed when D-glucose was increased in the assay mixture from zero to 4 mM (Fig. 6). Higher 
D-glucose concentrations could not be tested because of the contribution of glucose reduction to the 
overall AR activity. L-glucose is a very poor substrate for the enzyme. It is thus an ideal tool to 
evaluate the hemiacetal inhibition, since no contribution is expected in the activity measurements 
for at least up to 30 mM of the sugar. When L-glucose, rather than D-glucose, was used as a source 
of hemiacetal a progressive increase of the inhibitory effect on L-idose reduction was observed up 
to approximately 17%. The observed inhibitory effect may be underestimated, since it is impossible 
to measure the enzyme activity on long chain aldoses in the absence of the hemiacetal form. In fact, 
when the data related to the inhibition of L-glucose on L-idose reduction were analyzed by a 
nonlinear fitting program (see Section 2.4), the values of the rate extrapolated to a zero hemiacetal 
concentration (2.52 x 10-3 mM min-1) and to an infinitive hemiacetal concentration (1.86 x 10-3 mM 
min-1) revealed an inhibitory effect of approximately 26%. 
This result, together with the biphasic effect observed for several long chain aldoses (Fig. 3), 
suggests an apparent broad specificity of the enzyme for cyclic hemiacetals of different aldoses. 
The interaction, however, displays some specificity, since hemiketal structures, such as those 
generated by D-fructose and L-sorbose, did not affect the enzyme’s activity (Fig. 6). 
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The case of L-threose and D-erythrose is also worth noting; the reduction of these aldoses did not 
appear to be affected by their hemiacetal form. Either the furanosidic hemiacetal form, the only one 
compatible with 4 carbon atom aldoses, is unable to interact with the enzyme, or the hemiacetal/free 
aldehyde ratio is too low to generate a biphasic response. It is also possible that the molecular size 
and/or the hindrance of L-threose and D-erythrose enable the free aldehyde of these sugars to 
escape the inhibitory action of furanosidic hemiacetals. However, the fact that the reduction of these 
sugars, as also occurs for GAL, was not affected by L-glucose (data not shown), suggests that they 
are not affected by the perturbation of the AR active site induced by hemiacetals. 
On the basis of indications emerging from Eqs. 2, 5 and 7, it was possible to have insight in the 
mechanism of action of the hemiacetal on the free aldehyde reduction. The analysis of kinetic 
parameters measured for L-idose at different fixed levels of hemiacetal (Fig. 7) indicates that some 
effect on the catalytic step of aldehyde reduction may occur. In fact, an increase in apparent kcat, 
from 1.24 ± 0.48 s-1 to 2.32 ± 0.19 s-1 was observed (Fig.7, inset). More evident is the increase in 
apparent KM up to three fold, from approximately 1 µM (𝐾𝑚) to 3.4 µM (𝐾𝑚
′ ) , with the increase in 
hemiacetal concentration. The absolute values of these kinetic parameters may be debatable, 
because of the resulting rather high error. However, because of the high confidence limits of the 
data fitting, the trend of the parameters with the increase in hemiacetal concentration is 
unequivocal. The emerging values for the kinetic parameters related to the hemiacetal-bound AR 
(i.e. k+4 and  𝐾𝑚
′ ) are essentially the same as those previously measured for L-idose reduction 
analyzed in the high range of substrate concentrations [38]. Indeed, using the above kinetic 
parameters measured for L-idose, a biphasic double reciprocal plot, generated by a computer-
assisted simulation of Eq.2, was able to fit experimental results of Fig. 3 A, by imposing a value of 
𝐾𝑖 of 2.5 x 10
-4 M (Fig. 5). In principle, a partial uncompetitive inhibition model can also generate 
an apparent cooperative behavior (see Appendix, Sect.III). However, this inhibition model can be 
ruled out, since the biphasic curves in the double reciprocal plot would appear with an upward 
curvature, as would happen with an apparent positive cooperativity or substrate inhibition. This is 
strengthened by the progressive increase of apparent KM values of L-idose free aldehyde with the 
increase of hemiacetal concentration (Fig. 7, inset) which is incompatible with a uncompetitive 
inhibition model (Eq.7). As previously mentioned, our data are unable to discriminate between 
nonclassical competitive from mixed noncompetitive inhibition models. Thus the latter mechanism, 
which must be characterized in any event by a significant contribution of the competitive interaction 
(Fig. 5), cannot be ruled out. 
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In conclusion, our study would seem to indicate that a hydrophilic microenvironment, which is 
suitable to accomodate highly hydrophilic molecules with steric hindrance such as aldose 
hemiacetals, allows the enzyme modulation by one of its most important physiopathological 
substrates. It is difficult at the moment to envisage the physical placement of the hemiacetal on the 
enzyme. Nevertheless the flexibility and adaptability of the induced cavity region at the inhibitory 
site of AR [55, 56] may contribute to the hemiacetal binding. 
While providing a plausible interpretation of the apparent negative cooperative behavior of the 
reduction of glucose and, in more general terms, of long chain aldoses by AR, the effect reported 
here of the hemiacetal ring on the enzyme activity strengthens the particular interaction of AR with 
aldoses compared to other non-sugar substrates. This increases the possibility of intervening on the 
enzyme by a differential inhibitory action, aimed at targeting the enzyme while working on glucose 
without, or only partially, affecting the reduction of hydrophobic cytotoxic aldehydes such as 
alkenals or alkanals (Del Corso et al., 2013). In any event, although modest in terms of absolute 
values, the partial inhibitory action of aldose hemiacetals is worth considering when planning 
kinetic studies of AR in which the enzyme is targeted for inhibition to develop drugs against the 
onset of diabetic complications. In fact the presence of an additional species (i.e. the hemiacetal), 
trafficking in or near by  the AR active site, must be taken in consideration when performing in 
vitro studies for ARIs or ARDIs selection. 
Finally, we found that the apparent low efficiency of AR towards glucose, which has so often led to 
the enzyme not to being considered tailored for hydrophilic molecules, is not only dramatically 
affected by the low level of the free aldehyde form present in solution, but also by the subtle 
inhibitory effect exerted by the hemiacetal ring of glucose itself. 
 
 
APPENDIX 
Kinetic models for aldose reduction by aldose reductase 
Section I-Partial inhibition for a nonclassical competitive model of action of aldose hemiacetal on 
the free aldehyde reduction. 
By considering the kinetic model of Fig. 4 A in which an exclusive interaction of C with the free 
enzyme occurs and starting from the general rate equation for the transformation of A: 
𝑣0 =
𝑑[𝑃]
𝑑𝑡
=  𝑘+2[𝐸𝐴] + 𝑘+4[𝐸𝐶𝐴]                     (A.1) 
it follows: 
𝐾𝑖 =
[𝐸][𝐶]
[𝐸𝐶]
              (A.2) 
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𝑘+1[𝐸][𝐴] = (𝑘+2 + 𝑘−1)[𝐸𝐴]        (A. 3) 
𝑘+3[𝐸𝐶][𝐴] = (𝑘+4 + 𝑘−3)[𝐸𝐶𝐴]          (A.4) 
Different enzyme forms can be expressed in terms of [EA]. 
From Eq.(A.3): 
[𝐸] =
𝑘+2+𝑘−1
𝑘+1[𝐴]
[𝐸𝐴] =  
𝐾𝑚
[𝐴]
[𝐸𝐴]               (A.5) 
From Eq.(A.2) and Eq.(A.5): 
[𝐸𝐶] =
[𝐸][𝐶]
𝐾𝑖
=
𝐾𝑚[𝐶]
𝐾𝑖[𝐴]
[𝐸𝐴]      (A.6) 
From Eq. (A.4) and Eq. (A.6): 
[𝐸𝐶𝐴] =
𝑘+3[𝐸𝐶][𝐴]
𝑘+4+𝑘−3
=
𝐾𝑚[𝐶]
𝐾𝑚
′ 𝐾𝑖
[𝐸𝐴]            (A.7) 
Taking into account the mass balance for the enzyme (Eq. (A.8))  
𝐸𝑇 = [𝐸] + [𝐸𝐶] + [𝐸𝐶𝐴] + [𝐸𝐴]          (A.8) 
and normalizing the reaction rate v0 (Eq. (A.1)) for ET: 
𝑣0
𝐸𝑇
=
𝑘+2[𝐸𝐴] + 𝑘+4
𝐾𝑚[𝐶]
𝐾𝑖𝐾𝑚
′ [𝐸𝐴]
𝐾𝑚
[𝐴]
[𝐸𝐴] +
𝐾𝑚[𝐶]
𝐾𝑖[𝐴]
[𝐸𝐴] +
𝐾𝑚[𝐶]
𝐾𝑖𝐾𝑚
′ [𝐸𝐴] + [𝐸𝐴]
 
Simplifying for [EA], 
𝑣0 =
𝐸𝑇(𝑘+2+𝑘+4
𝐾𝑚[𝐶]
𝐾𝑖𝐾𝑚
′ )
𝐾𝑚
[𝐴]
+
𝐾𝑚[𝐶]
𝐾𝑖[𝐴]
+
𝐾𝑚[𝐶]
𝐾𝑖𝐾𝑚
′ +1
         (A.9) 
Equation A.9 enables the effect exerted on the reaction rate by the concentration of both the 
hemiacetal ring and the sugar free aldehyde to be predicted. When one of these two parameters is 
kept constant, the dependence of the reaction rate on the other parameter is of hyperbolic type. At a 
fixed level of hemiacetal (i.e. [C] = constant), Eq. A.9 can be rewritten to appear in the usual form 
of a rectangular hyperbola: 
𝑣0 =
𝐸𝑇
𝑘+2𝐾𝑚
′ 𝐾𝑖+𝑘+4𝐾𝑚[𝐶]
𝐾𝑚[𝐶]+𝐾𝑚
′ 𝐾𝑖
[𝐴]
𝐾𝑚𝐾𝑚
′ (𝐾𝑖+[𝐶])
𝐾𝑚
′ 𝐾𝑖+𝐾𝑚[𝐶]
+[𝐴]
           (A.10, Eq. 2 in the text) 
In order to express [𝐶] and [𝐴] in terms of total glucose concentration [𝐺], being: 
[𝐶] + [𝐴] = [𝐺]            (A.11) 
and 
[𝐶]
[𝐴]
= 𝑅             (A.12) 
it follows that: 
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[𝐴] =
[𝐺]
𝑅+1
     and    [𝐶] =
𝑅[𝐺]
𝑅+1
   
The substitution in Eq.(A.9) gives: 
𝑣0 =
𝐸𝑇{𝑘+2 𝐾𝑚
′ 𝐾𝑖 (𝑅 + 1) + 𝑘+4𝐾𝑚𝑅[𝐺]}
(𝑅 + 1) (
𝐾𝑚 𝐾𝑚
′ 𝐾𝑖 (𝑅+1)
[𝐺]
+
𝐾𝑚 𝐾𝑚
′ 𝐾𝑖 𝑅
𝐾𝑖
+ 
𝐾𝑚 𝐾𝑚
′ 𝐾𝑖 𝑅[𝐺]
 𝐾𝑚
′  𝐾𝑖(𝑅+1)
+ 𝐾𝑖  𝐾𝑚′ )
 
After simplification and simple algebra steps, the following results: 
𝑣0 =
𝐸𝑇{𝑘+2 𝐾𝑚
′  𝐾𝑖
′(𝑅+1)[𝐺]+𝑘+4𝐾𝑚𝑅[𝐺]
2} 
 𝐾𝑚𝐾𝑚
′ 𝐾𝑖(𝑅+1)2+ 𝐾𝑚
′ (𝐾𝑚𝑅+𝐾𝑖)(𝑅+1)[𝐺]+𝐾𝑚𝑅[𝐺]2
         (A.13, Eq.3 in the text) 
This equation describes the dependence of the reaction rate on the concentration of glucose and, 
imposing 𝐾𝑚 < 𝐾𝑚
′  it fits with an apparent negative cooperative behavior (i.e. downward curvature 
in the double reciprocal plots) as that observed for long chain aldoses (see text, Figs. 1 and 3). 
 
 
Section II-Partial inhibition for a mixed noncompetitive model of action of aldose hemiacetal on 
free aldehyde reduction. 
When the model of Fig. 4 B is analyzed considering EC and EAC at equilibrium, and EA and ECA 
in steady state conditions, the general rate equation for the transformation of A: 
𝑣0 =
𝑑[𝑃]
𝑑𝑡
=  𝑘+2[𝐸𝐴] + 𝑘+4([𝐸𝐴𝐶] + [𝐸𝐶𝐴]) 
becomes : 
𝑣0 =
𝐸𝑇{𝑘+2 + 𝑘+4(
[𝐶]
 𝐾𝑖
′ + 
𝐾𝑚[𝐶]
 𝐾𝑚
′ 𝐾𝑖
)}
𝐾𝑚
[𝐴]
 + 
𝐾𝑚[𝐶]
𝐾𝑖[𝐴]
 + 
𝐾𝑚[𝐶]
𝐾𝑖 𝐾𝑚
′  + 
[𝐶]
 𝐾𝑖
′+1
      (A.14) 
Equation (A.14) describes the dependence of the reaction rate of glucose reduction as a function of 
the aldose free aldehyde and aldose hemiacetal concentrations in the case of partial mixed 
noncompetitive type of inhibition. When one of these two terms is kept constant, v0 versus the 
second one is described again by a rectangular hyperbola (Eq. (A.15)) 
𝑣0 =
𝐸𝑇(  𝑘+2𝐾𝑚
′  𝐾𝑖
′  𝐾𝑖+ 𝑘+4(𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐶])
 𝐾𝑚
′  𝐾𝑖
′  𝐾𝑖 + (𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐶]
[𝐴]
𝐾𝑚 𝐾𝑚
′ 𝐾𝑖
′(𝐾𝑖+[𝐶])
 𝐾𝑚
′  𝐾𝑖𝐾𝑖
′ + (𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐶]
  + [𝐴]
   (A.15, Eq.5 in the text) 
When reformulated in terms of total glucose concentration [G], Eq. (A.15) becomes: 
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𝑣0 =
𝐸𝑇{𝑘+2 𝐾𝑚
′ 𝐾𝑖 𝐾𝑖
′(𝑅+1)[𝐺]+𝑘+4𝑅(𝐾𝑚 𝐾𝑖
′+ 𝐾𝑚
′ 𝐾𝑖)[𝐺]
2}
𝐾𝑚 𝐾𝑚
′ 𝐾𝑖 𝐾𝑖
′(𝑅+1)2+ 𝐾𝑚
′  𝐾𝑖
′(𝑅+1)(𝐾𝑚𝑅+𝐾𝑖)[𝐺]+ 𝑅(𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐺]2
  
                                                                                                                    (A.16, Eq.6 in the text) 
Equation (A.16) predicts the dependence of the reaction rate of aldose reduction versus the total 
aldose concentration in the case of the mixed noncompetitive type of partial inhibition. Computer-
aided simulations of double reciprocal plots of Eq. (A.16) end either with upward or downward 
curves depending on the imposed relative values of 𝐾𝑖 and 𝐾𝑖
′ (see text, Fig. 5). 
 
 
Section III- Partial inhibition for an uncompetitive model of action of aldose hemiacetal on free 
aldehyde reduction. 
When the model of Fig. 4 C is analyzed considering EAC at equilibrium and EA in steady state 
conditions, the general rate equation for the transformation of A: 
𝑣0 =
𝑑[𝑃]
𝑑𝑡
=  𝑘+2[𝐸𝐴] + 𝑘+4[𝐸𝐴𝐶] 
becomes: 
𝑣0 =
𝐸𝑇(𝑘+2+𝑘+4
[𝐶]
𝐾𝑖
′)
𝐾𝑚
[𝐴]
+
[𝐶]
𝐾𝑖
′+1
         (A.17) 
Equation (A.17) describes the dependence of the reaction rate of glucose reduction as a function of 
the aldose free aldehyde and aldose hemiacetal concentrations in the case of a partial uncompetitive 
type of inhibition. When one of these two terms is kept constant, v0 versus the second one is 
described again by a rectangular hyperbola:  
𝑣0 =
𝐸𝑇(𝑘+2𝐾𝑖
′+𝑘+4[𝐶])
(𝐾𝑖
′+[𝐶])
[𝐴]
𝐾𝑚𝐾𝑖
′
𝐾𝑖
′+[𝐶]
+[𝐴]
                      (A.18, Eq.7 in the text) 
Making use of Eqs.(A.11) and (A.12), Eq. (A.18) can be reformulated in order to express the 
reaction rate in terms of total glucose concentration:  
𝑣0 =
𝐸𝑇{𝑘+2𝐾𝑖
′(𝑅+1)[𝐺]+𝑘+4𝑅[𝐺]
2}
𝐾𝑚𝐾𝑖
′(𝑅+1)2+𝐾𝑖
′(𝑅+1)[𝐺]+𝑅[𝐺]2
   (A.19, Eq.8 in the text) 
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This equation, similarly to what obtained for a partial nonclassical competitive inhibition model 
(Eq. (A.13)), predicts for the partial uncompetitive inhibition an apparent cooperative dependence 
of the reaction rate on the total glucose concentration. However, in this case, the biphasic curves in 
the double reciprocal plots would appear with an upward curvature as occurs for apparent positive 
cooperativity or substrate inhibition models. This would not fit with the downward curves observed 
for long chain aldoses (see text, Figs. 1 and 3). 
 
 
Section IV-In defining the model of partial inhibition for aldose hemiacetal on free aldehyde 
reduction. 
By exploiting the hyperbolic behavior displayed by nonclassical competitive,  mixed and 
uncompetitive types of partial inhibition (Eqs. (A.10), (A.15) and (A.18), respectively), when 
reaction rates as a function of the substrate concentration (i.e. free aldehyde form of the aldose) are 
measured at different fixed concentrations of the inhibitor, an array of straight lines for all models 
will be generated in double reciprocal plots. The secondary plots of intercepts with the ordinate axis 
(𝑉𝑚𝑎𝑥𝑎𝑝𝑝) and with the abscissa axis (𝐾𝑀
𝑎𝑝𝑝
) versus the aldose hemiacetal concentration related to 
different kinetic models are described as follows:  
a) For the nonclassical competitive partial inhibition (nc)  
(𝑛𝑐)𝑉𝑚𝑎𝑥𝑎𝑝𝑝 = 𝐸𝑇 (
𝑘+2 𝐾𝑚
′ 𝐾𝑖+𝑘+4𝐾𝑚[𝐶]
 𝐾𝑚
′ 𝐾𝑖+𝐾𝑚[𝐶]
)   (A.20)  
(𝑛𝑐)𝐾𝑀
𝑎𝑝𝑝 =
𝐾𝑚 𝐾𝑚
′ 𝐾𝑖+𝐾𝑚 𝐾𝑚
′ [𝐶]
 𝐾𝑚
′ 𝐾𝑖+𝐾𝑚[𝐶]
                (A.21)  
b) For the uncompetitive partial inhibition (uc) 
(𝑢𝑐)𝑉𝑚𝑎𝑥
𝑎𝑝𝑝 = 𝐸𝑇 (
𝑘+2𝐾𝑖+𝑘+4[𝐶]
𝐾𝑖+[𝐶]
)     (A.22) 
(𝑢𝑐)𝐾𝑀
𝑎𝑝𝑝 =
𝐾𝑚 𝐾𝑖
′
 𝐾𝑖
′+[𝐶]
           (A.23)  
c) For the mixed noncompetitive partial inhibition (mix) 
(𝑚𝑖𝑥)𝑉𝑚𝑎𝑥
𝑎𝑝𝑝 = 𝐸𝑇 (
𝐸𝑇{𝑘+2 𝐾𝑚
′ 𝐾𝑖 𝐾𝑖
′+𝑘+4(𝐾𝑚 𝐾𝑖
′+𝐾𝑚
′ 𝐾𝑖)[𝐶]
 𝐾𝑚
′  𝐾𝑖  𝐾𝑖
′ + (𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐶]
)                 (A.24)  
(𝑚𝑖𝑥)𝐾𝑀
𝑎𝑝𝑝 =
𝐾𝑚 𝐾𝑚
′  𝐾𝑖  𝐾𝑖
′(1+[𝐶])
 𝐾𝑚
′  𝐾𝑖  𝐾𝑖
′  + (𝐾𝑚 𝐾𝑖
′ + 𝐾𝑚
′ 𝐾𝑖)[𝐶]
                      (A.25)  
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Section V-The action of hemiacetal acting as competitive substrate of the free aldehyde for AR is 
described by a hyperbola. 
In the search for models able to fit the apparent cooperative behavior displayed by AR in reducing 
glucose, the possibility that glucose hemiacetal can bind the enzyme and undergo reduction 
competing with the free aldehyde form was considered (Fig. A.1). 
This model of two antagonist competitive substrates for the same enzyme was previously shown to 
be described by a hyperbolic kinetic equation with respect to each substrate (44). In the present 
case, in which both substrates are transformed into the same product, the equation predicting the 
effect exerted on the reaction rate by the concentration of both the hemiacetal ring and the sugar 
free aldehyde can be formulated (Eq. (A.26)): 
𝑣0 =
𝐸𝑇(𝑘+2𝐾𝑀
𝐶 [𝐴]+𝑘+4𝐾𝑀
𝐴 [𝐶]) 
𝐾𝑀
𝐴 𝐾𝑀
𝐶 +𝐾𝑀
𝐴 [𝐶]+𝐾𝑀
𝐶 [𝐴]
                       (A.26) 
in which 𝐾𝑀
𝐴 and 𝐾𝑀
𝐶   represent the Michaelis constants of AR for the free aldehyde and hemiacetal, 
respectively. As shown, when one of these two supposed substrates is kept constant, the dependence 
of the reaction rate on the remaining one is hyperbolic. No assumptions were made concerning the 
reaction pathway of reduction of the hemiacetal. However, in any case, an in situ opening step of 
the hemiacetal ring on the enzyme, which may end up as EA, must be presumed. The only 
restriction imposed on the scheme is the occurrence of a fast return of E’ to E, a restraint which 
would conceivably force the system to be described by a hyperbolic function. However, conditions 
with the potential to induce non-equilibrium measurements, such as a slow equilibration between E’ 
and E, which may generate apparent cooperative behavior, would be  buffered in the case of aldoses 
in which both free aldehyde and the supposed hemiacetal substrate are in equilibrium and 
simultaneously change at a constant ratio. Thus, in order to express the reaction rate in terms of 
total glucose concentration [𝐺], using Eqs.(A.11) and (A.12), Eq. (A.26) can be reformulated and 
expressed in the usual form of a rectangular hyperbola (Eq. (A.27)): 
𝑣0 =
𝐸𝑇(𝑘+2𝐾𝑀
𝐶 +𝑘+4𝐾𝑀
𝐴 𝑅)
𝐾𝑀
𝐴 𝑅+𝐾𝑀
𝐶 [𝐺]
𝐾𝑀
𝐴 𝐾𝑀
𝐶 (𝑅+1)
𝐾𝑀
𝐴 𝑅+𝐾𝑀
𝐶 +[𝐺]
                  (A.27) 
This result does not appear to support the hypotheses of the participation of the hemiacetal form as 
an alternative substrate to the aldose free aldehyde in generating the apparent cooperative behavior 
displayed by AR in reducing aldoses. 
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FIGURE 1. The reduction of D-glucose catalyzed by aldose reductase. The initial rate 
measurements of the reduction of D-glucose in the presence of either bAR at a final concentration 
of 11 mU mL-1 (Panel A), or hAR at a final concentration of 53 mU mL-1 (Panel B), are reported in 
double reciprocal plots. Straight lines interpolating experimental data were drawn on the basis of 
the kinetic parameters evaluated by nonlinear regression analysis. Error bars (when not visible are 
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within the symbol size) represent the standard deviations of the mean, from at least three 
independent measurements. 
 
 
FIGURE 2. Double reciprocal plots for the reduction of different aldehydes catalyzed by aldose 
reductase. The initial rate measurements of the reduction of different AR substrates are reported as 
double reciprocal plots. Panel A: GAL (open triangles), HNE (closed triangles); Panels B, C and D 
refer to 4-nitrobenzaldehyde, L-threose and D-erythrose, respectively. The assays were performed 
in the presence of hAR at a final concentration of 7 mU mL-1 for GAL, HNE and 4-
nitrobenzaldehyde and 14 mU mL-1 for threose and erythrose. Error bars (when not visible are 
within the symbol size) represent the standard deviations of the mean from at least three 
independent measurements. Straight lines interpolating experimental data were drawn on the basis 
of the kinetic parameters evaluated by nonlinear regression analysis. 
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FIGURE 3. Double reciprocal plots for the reduction of different aldoses catalyzed by aldose 
reductase. The initial rate measurements of the reduction of L-idose (Panel A), D-galactose (Panel 
B), D-ribose (Panel C) and D-xylose (Panel D) are reported as double reciprocal plots. The assays 
were performed in the presence of hAR at a final concentration of 16 mU mL-1 for L-idose, 14 mU 
mL-1 for D-ribose and D-xylose and 36 mU mL-1 for D-galactose. Error bars (when not visible are 
within the symbols size) represent the standard deviations of the mean from at least three 
independent measurements. Straight lines were drawn at high and low concentration ranges of 
different aldoses on the basis of the kinetic parameters evaluated by nonlinear regression analysis. 
Highest values of the low concentration ranges are. 0.9, 1.5, 2 and 50 mM for D-xylose, L-idose, D-
ribose and D-galactose, respectively. 
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FIGURE 4. Kinetic models for aldose reduction by AR. The symbols A and C represent the aldose 
free aldehyde and the hemiacetal form, respectively. EA and EC represent the binary complexes of 
AR with A and C, respectively, while ECA and EAC represent the ternary complexes which derive 
from the two indicated interaction pathways. Lower case “k” refer to kinetic constants; upper case 
“K” refer to dissociation equilibrium constants. Panel A: model of partial nonclassical competitive 
inhibition exerted by the hemiacetal on aldose reduction. Panel B: model of partial mixed 
noncompetitive inhibition. Panel C: model of partial uncompetitive inhibition.  
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FIGURE 5. Simulation of the apparent negative cooperative behavior of AR acting on L-idose. 
Double reciprocal plots of reaction rates (v0/ET) versus L-idose concentration were generated by 
computer-assisted simulation either using Eq. 3, which describes the kinetic model of partial 
nonclassical competitive inhibition (curve 1), or using Eq. 6, which describes the kinetic model of 
partial mixed noncompetitive inhibition (curves 2 to 5). Curve 1 originates from Eq. 3 using the 
values of 1.0 µM and 3.4 µM for 𝐾𝑚 and  𝐾𝑚
′ , respectively, and values of 1.24 s-1 and 2.32 s-1 for  
k+2 and for k+4, respectively, as derived from the present study and by imposing a Ki of 2.5 x 10
-4 
M. Curves 2, 3, 4 and 5 were generated from Eq. 6 using the above parameters and a  𝐾𝑖
′ 𝐾𝑖⁄  ratio of 
0.5, 2, 10 and 50, respectively. 
 
 
FIGURE 6. Effect of different hemiacetals/hemiketals on aldose reduction. The reaction rate of L-
idose reduction was measured using 0.4 mM of the aldose at the indicated concentrations of the 
following: D-glucose (closed diamonds), L-glucose (open diamonds), D-fructose (open triangles) 
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and D-sorbose (open circles). Closed squares refer to the reduction of 2 mM D-ribose in the 
presence of the indicated L-glucose concentration. The hAR present in the assay mixture accounted 
for 21 mU mL-1 and the reaction rate is expressed as a percentage of the value measured in the 
absence of effectors. The abscissa values represent the total concentration of hemiacetals plus 
hemiketals present in the assay mixtures. 
 
 
FIGURE 7. Kinetic analysis of the inhibition of L-idose reduction by aldose hemiacetal. Assay 
mixtures were assembled in order to measure the rate of the reduction of L-idose at different 
substrate concentrations and at different levels of L-glucose by keeping the total hemiacetal 
concentration (L-glucose hemiacetal plus L-idose hemiacetal) constant. The data, reported in a 
double reciprocal plot, refer to total hemiacetal concentrations ranging from 1 mM (closed 
diamonds) to 20 mM (open squares). Straight lines interpolating experimental data were drawn on 
the basis of the kinetic parameters evaluated by nonlinear regression analysis. In the Inset, the 
values of apparent KM (circles) and apparent kcat (squares) are reported in a secondary plot as a 
function of the total hemiacetal concentration. The limit values at zero and at the saturating 
hemiacetal concentration were determined through the analysis of the data by nonlinear fitting 
method with a confidence limit of 90% and a Pearson coefficient (R) of 0.999 (see Section 2.4). 
Assays were performed using 34 mU mL-1 of hAR. 
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FIGURE A.1. Aldose reduction by AR through the participation of the hemiacetal (C) as substrate.  
A and C represent the aldehyde open chain of the aldose and the closed hemiacetal form, 
respectively. EA and EC represent the binary complexes of AR with A and C, respectively. E’C and 
E’A represent generic forms of the EC evolution bringing the complex toward product formation; E’ 
represents the free enzyme form as it comes from the catalytic step. Lower case constants refer to 
kinetic constants. 
 
 
